A Mayo Clinic allergist and colleagues representing the American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma and Immunology announce they are revising the old classification of asthma patients by disease severity to determine treatment and moving to a new expectation for all asthma patients: excellent symptom control. Complete or total control is also a realistic goal for a subset of patients, according to new guidelines for treating asthma published in the November issue of Journal of Allergy and Clinical Immunology.
"People with asthma can expect to control the asthma: not to have the asthma control them," says James Li, M.D., Ph.D., Mayo Clinic allergist and lead author of the paper. "It’s all about asthmatics’ quality of life: waking up in the middle of the night wheezing, constantly using rescue medications, having to excuse themselves from sports teams or needing to leave work due to an attack -- that’s no life."
Dr. Li contends this is not just pie-in-the-sky thinking, but that these new goals can align with patients’ disease reality. "It’s definitely not only a goal and an ideal, but most people with asthma can have well or completely controlled asthma," he says. "People with asthma should not be satisfied with less than well or completely controlled asthma. We want to empower patients by letting them know this is the goal. We want them to know if they are not reaching this goal, they should see their doctors."
The authors also assert that with proper symptom assessment and treatment, complete or total control is possible for a significant group of asthmatics.
"While well-controlled asthma is the recommended target for all patients with asthma, complete control may be attainable and appropriate for many patients," says Dr. Li.
Complete or total control of asthma is defined by Dr. Li and colleagues as follows:
Asthma is a chronic condition that occurs when the main air passages of the lungs, the bronchial tubes, become inflamed. The muscles of the bronchial walls tighten and extra mucus is produced, causing the airways to narrow. This can lead to everything from minor wheezing to severe difficulty in breathing. Each year, nearly 500,000 Americans with asthma are hospitalized, and more than 4,000 die from disease-related causes.
Spread of deadly eye cancer halted in cells and animals
13.11.2018 | Johns Hopkins Medicine
Breakthrough in understanding how deadly pneumococcus avoids immune defenses
13.11.2018 | University of Liverpool
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly
The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
13.11.2018 | Life Sciences
13.11.2018 | Life Sciences
13.11.2018 | Awards Funding